Type 1 Gaucher disease (CYP2D6-eliglustat)

Gespeichert in:

Autor*in:	Becquemont, Laurent [verfasserIn]

Format:	Artikel
Sprache:	Französisch

Erschienen:	2017

Übergeordnetes Werk:	Enthalten in: Thérapie - Issy-les-Moulineaux : Elsevier, 1946, (2017)
Übergeordnetes Werk:	year:2017

Links:	Volltext

DOI / URN:	10.1016/j.therap.2016.09.019

Katalog-ID:	OLC1990125069

Internformat


LEADER	01000caa a2200265 4500
001	OLC1990125069
003	DE-627
005	20230715031028.0
007	tu
008	170303s2017 xx \|\|\|\|\| 00\| \|\|fre c
024	7		\|a 10.1016/j.therap.2016.09.019 \|2 doi
028	5	2	\|a PQ20170301
035			\|a (DE-627)OLC1990125069
035			\|a (DE-599)GBVOLC1990125069
035			\|a (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190
035			\|a (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a fre
082	0	4	\|a 610 \|q DE-600
100	1		\|a Becquemont, Laurent \|e verfasserin \|4 aut
245	1	0	\|a Type 1 Gaucher disease (CYP2D6-eliglustat)
264		1	\|c 2017
336			\|a Text \|b txt \|2 rdacontent
337			\|a ohne Hilfsmittel zu benutzen \|b n \|2 rdamedia
338			\|a Band \|b nc \|2 rdacarrier
773	0	8	\|i Enthalten in \|t Thérapie \|d Issy-les-Moulineaux : Elsevier, 1946 \|g (2017) \|w (DE-627)130397423 \|w (DE-600)603474-3 \|w (DE-576)015900436 \|x 0040-5957 \|7 nnns
773	1	8	\|g year:2017
856	4	1	\|u http://dx.doi.org/10.1016/j.therap.2016.09.019 \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a SSG-OLC-FRK
912			\|a SSG-OLC-ROK
912			\|a SSG-OLC-PHA
912			\|a SSG-OLC-DE-84
912			\|a GBV_ILN_4219
951			\|a AR
952			\|j 2017

Indexfelder

author_variant	l b lb
matchkey_str	article:00405957:2017----::yeguhriescpd
hierarchy_sort_str	2017
publishDate	2017
allfields	10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017
spelling	10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017
allfields_unstemmed	10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017
allfieldsGer	10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017
allfieldsSound	10.1016/j.therap.2016.09.019 doi PQ20170301 (DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat DE-627 ger DE-627 rakwb fre 610 DE-600 Becquemont, Laurent verfasserin aut Type 1 Gaucher disease (CYP2D6-eliglustat) 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Enthalten in Thérapie Issy-les-Moulineaux : Elsevier, 1946 (2017) (DE-627)130397423 (DE-600)603474-3 (DE-576)015900436 0040-5957 nnns year:2017 http://dx.doi.org/10.1016/j.therap.2016.09.019 Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219 AR 2017
language	French
source	Enthalten in Thérapie (2017) year:2017
sourceStr	Enthalten in Thérapie (2017) year:2017
format_phy_str_mv	Article
institution	findex.gbv.de
dewey-raw	610
isfreeaccess_bool	false
container_title	Thérapie
authorswithroles_txt_mv	Becquemont, Laurent @@aut@@
publishDateDaySort_date	2017-01-01T00:00:00Z
hierarchy_top_id	130397423
dewey-sort	3610
id	OLC1990125069
language_de	franzoesisch
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1990125069</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230715031028.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">170303s2017 xx \|\|\|\|\| 00\| \|\|fre c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.therap.2016.09.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20170301</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1990125069</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1990125069</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)crossref_primary_10_1016_j_therap_2016_09_0190</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">fre</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Becquemont, Laurent</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Type 1 Gaucher disease (CYP2D6-eliglustat)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Thérapie</subfield><subfield code="d">Issy-les-Moulineaux : Elsevier, 1946</subfield><subfield code="g">(2017)</subfield><subfield code="w">(DE-627)130397423</subfield><subfield code="w">(DE-600)603474-3</subfield><subfield code="w">(DE-576)015900436</subfield><subfield code="x">0040-5957</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2017</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1016/j.therap.2016.09.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-FRK</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-ROK</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2017</subfield></datafield></record></collection>
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1990125069</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230715031028.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">170303s2017 xx \|\|\|\|\| 00\| \|\|fre c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.therap.2016.09.019</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20170301</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1990125069</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1990125069</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)crossref_primary_10_1016_j_therap_2016_09_0190</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">fre</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Becquemont, Laurent</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Type 1 Gaucher disease (CYP2D6-eliglustat)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Thérapie</subfield><subfield code="d">Issy-les-Moulineaux : Elsevier, 1946</subfield><subfield code="g">(2017)</subfield><subfield code="w">(DE-627)130397423</subfield><subfield code="w">(DE-600)603474-3</subfield><subfield code="w">(DE-576)015900436</subfield><subfield code="x">0040-5957</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2017</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1016/j.therap.2016.09.019</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-FRK</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-ROK</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2017</subfield></datafield></record></collection>
author	Becquemont, Laurent
spellingShingle	Becquemont, Laurent ddc 610 Type 1 Gaucher disease (CYP2D6-eliglustat)
authorStr	Becquemont, Laurent
ppnlink_with_tag_str_mv	@@773@@(DE-627)130397423
format	Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut
collection	OLC
remote_str	false
illustrated	Not Illustrated
issn	0040-5957
topic_title	610 DE-600 Type 1 Gaucher disease (CYP2D6-eliglustat)
topic	ddc 610
topic_unstemmed	ddc 610
topic_browse	ddc 610
format_facet	Aufsätze Gedruckte Aufsätze
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	nc
hierarchy_parent_title	Thérapie
hierarchy_parent_id	130397423
dewey-tens	610 - Medicine & health
hierarchy_top_title	Thérapie
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)130397423 (DE-600)603474-3 (DE-576)015900436
title	Type 1 Gaucher disease (CYP2D6-eliglustat)
ctrlnum	(DE-627)OLC1990125069 (DE-599)GBVOLC1990125069 (PRQ)crossref_primary_10_1016_j_therap_2016_09_0190 (KEY)0000038820170000000000000000type1gaucherdiseasecyp2d6eliglustat
title_full	Type 1 Gaucher disease (CYP2D6-eliglustat)
author_sort	Becquemont, Laurent
journal	Thérapie
journalStr	Thérapie
lang_code	fre
isOA_bool	false
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2017
contenttype_str_mv	txt
author_browse	Becquemont, Laurent
class	610 DE-600
format_se	Aufsätze
author-letter	Becquemont, Laurent
doi_str_mv	10.1016/j.therap.2016.09.019
dewey-full	610
title_sort	type 1 gaucher disease (cyp2d6-eliglustat)
title_auth	Type 1 Gaucher disease (CYP2D6-eliglustat)
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-FRK SSG-OLC-ROK SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_4219
title_short	Type 1 Gaucher disease (CYP2D6-eliglustat)
url	http://dx.doi.org/10.1016/j.therap.2016.09.019
remote_bool	false
ppnlink	130397423
mediatype_str_mv	n
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1016/j.therap.2016.09.019
up_date	2024-07-03T23:48:31.314Z
_version_	1803603684956831744
score	7.4000015

Nicht das Richtige dabei?

Schreiben Sie uns!

Type 1 Gaucher disease (CYP2D6-eliglustat)

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?